Human trials showed that in people with high-risk features, treatment with minocycline reduced in 6 months the risk of conversion to MS, decreased lesion volume, and showed the absence of new enhancing lesions, but this effect did not last beyond 24 months of study (Preiningerova et al., 2022)
If you are interested in starting peptide therapy, you should be in good general health and have realistic expectations regarding your results
Induction of gallstones in mice by feeding a cholesterol-cholic acid containing diet
Its not necessary to take supplements unless a healthcare professional has confirmed that youre deficient in a specific B vitamin
Ni Lochlainn M, Bowyer RCE, Moll JM, Garcia MP, Wadge S, Baleanu AF, Nessa A, Sheedy A, Akdag G, Hart D, et al